Literature DB >> 19240176

Radiotherapy decreases vascular density and causes hypoxia with macrophage aggregation in TRAMP-C1 prostate tumors.

Fang-Hsin Chen1, Chi-Shiun Chiang, Chun-Chieh Wang, Chien-Sheng Tsai, Shih-Ming Jung, Chung-Chi Lee, William H McBride, Ji-Hong Hong.   

Abstract

PURPOSE: To investigate how single or fractionated doses of radiation change the microenvironment in transgenic adenocarcinoma of the mouse prostate (TRAMP)-C1 tumors with respect to vascularity, hypoxia, and macrophage infiltrates. EXPERIMENTAL
DESIGN: Murine prostate TRAMP-C1 tumors were grown in C57BL/6J mice to 4 mm tumor diameter and were irradiated with either 25 Gy in a single dose or 60 Gy in 15 fractions. Changes in vascularity, hypoxia, and macrophage infiltrates were assessed by immunohistochemistry and molecular assays.
RESULTS: Tumor growth was delayed for 1 week after both radiation schedules. Tumor microvascular density (MVD) progressively decreased over a 3-week period to nadirs of 25% and 40% of unirradiated tumors for single or fractionated treatment, respectively. In accord with the decrease in MVDs, mRNA levels of endothelial markers, such as CD31, endoglin, and TIE, decreased over the same time period after irradiation. Central dilated vessels developed surrounded by avascularized hypoxic regions that became infiltrated with aggregates of CD68+ tumor-associated macrophages, reaching a maximum at 3 weeks after irradiation. Necrotic regions decreased and were more dispersed.
CONCLUSION: Irradiation of TRAMP-C1 tumors with either single or fractionated doses decreases MVD, leading to the development of disperse chronic hypoxic regions, which are infiltrated with CD68+ tumor-associated macrophages. Approaches to interfere in the development of these effects are promising strategies to enhance the efficacy of cancer radiotherapy.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19240176      PMCID: PMC2868361          DOI: 10.1158/1078-0432.CCR-08-1471

Source DB:  PubMed          Journal:  Clin Cancer Res        ISSN: 1078-0432            Impact factor:   12.531


  42 in total

1.  Regulation of p53 by hypoxia: dissociation of transcriptional repression and apoptosis from p53-dependent transactivation.

Authors:  C Koumenis; R Alarcon; E Hammond; P Sutphin; W Hoffman; M Murphy; J Derr; Y Taya; S W Lowe; M Kastan; A Giaccia
Journal:  Mol Cell Biol       Date:  2001-02       Impact factor: 4.272

Review 2.  Macrophage polarization: tumor-associated macrophages as a paradigm for polarized M2 mononuclear phagocytes.

Authors:  Alberto Mantovani; Silvano Sozzani; Massimo Locati; Paola Allavena; Antonio Sica
Journal:  Trends Immunol       Date:  2002-11       Impact factor: 16.687

3.  Anti-angiogenesis: new concept for therapy of solid tumors.

Authors:  J Folkman
Journal:  Ann Surg       Date:  1972-03       Impact factor: 12.969

4.  Prognostic value of tumor-associated macrophage count in human bladder cancer.

Authors:  T Hanada; M Nakagawa; A Emoto; T Nomura; N Nasu; Y Nomura
Journal:  Int J Urol       Date:  2000-07       Impact factor: 3.369

Review 5.  The role of hypoxia inducible factor 1 (HIF-1) in hypoxia induced apoptosis.

Authors:  A E Greijer; E van der Wall
Journal:  J Clin Pathol       Date:  2004-10       Impact factor: 3.411

6.  Vascular endothelial growth factor C is required for sprouting of the first lymphatic vessels from embryonic veins.

Authors:  Marika J Karkkainen; Paula Haiko; Kirsi Sainio; Juha Partanen; Jussi Taipale; Tatiana V Petrova; Michael Jeltsch; David G Jackson; Marja Talikka; Heikki Rauvala; Christer Betsholtz; Kari Alitalo
Journal:  Nat Immunol       Date:  2003-11-23       Impact factor: 25.606

Review 7.  Mechanisms regulating the recruitment of macrophages into hypoxic areas of tumors and other ischemic tissues.

Authors:  Craig Murdoch; Athina Giannoudis; Claire E Lewis
Journal:  Blood       Date:  2004-07-01       Impact factor: 22.113

8.  Tumor response to radiotherapy regulated by endothelial cell apoptosis.

Authors:  Monica Garcia-Barros; Francois Paris; Carlos Cordon-Cardo; David Lyden; Shahin Rafii; Adriana Haimovitz-Friedman; Zvi Fuks; Richard Kolesnick
Journal:  Science       Date:  2003-05-16       Impact factor: 47.728

Review 9.  Targeting HIF-1 for cancer therapy.

Authors:  Gregg L Semenza
Journal:  Nat Rev Cancer       Date:  2003-10       Impact factor: 60.716

Review 10.  Plasticity of macrophage function during tumor progression: regulation by distinct molecular mechanisms.

Authors:  Subhra K Biswas; Antonio Sica; Claire E Lewis
Journal:  J Immunol       Date:  2008-02-15       Impact factor: 5.422

View more
  48 in total

1.  Sunitinib Treatment-elicited Distinct Tumor Microenvironment Dramatically Compensated the Reduction of Myeloid-derived Suppressor Cells.

Authors:  Sheng-Yung Fu; Chun-Chieh Wang; Fang-Hsin Chen; Ching-Fang Yu; Ji-Hong Hong; Chi-Shiun Chiang
Journal:  In Vivo       Date:  2020 May-Jun       Impact factor: 2.155

Review 2.  Inhibiting vasculogenesis after radiation: a new paradigm to improve local control by radiotherapy.

Authors:  Brown J Martin
Journal:  Semin Radiat Oncol       Date:  2013-10       Impact factor: 5.934

Review 3.  The Promise of Targeting Macrophages in Cancer Therapy.

Authors:  J Martin Brown; Lawrence Recht; Samuel Strober
Journal:  Clin Cancer Res       Date:  2017-03-24       Impact factor: 12.531

Review 4.  Vasculogenesis: a crucial player in the resistance of solid tumours to radiotherapy.

Authors:  J M Brown
Journal:  Br J Radiol       Date:  2014-03       Impact factor: 3.039

5.  Arterial perfusion imaging-defined subvolume of intrahepatic cancer.

Authors:  Hesheng Wang; Reza Farjam; Mary Feng; Hero Hussain; Randall K Ten Haken; Theodore S Lawrence; Yue Cao
Journal:  Int J Radiat Oncol Biol Phys       Date:  2014-03-07       Impact factor: 7.038

Review 6.  The role of macrophage phenotype in regulating the response to radiation therapy.

Authors:  Xiaoshan Shi; Stephen L Shiao
Journal:  Transl Res       Date:  2017-11-20       Impact factor: 7.012

7.  Local control rates of metastatic renal cell carcinoma (RCC) to the bone using stereotactic body radiation therapy: Is RCC truly radioresistant?

Authors:  Arya Amini; Basel Altoos; Maria T Bourlon; Edward Bedrick; Shilpa Bhatia; Elizabeth R Kessler; Thomas W Flaig; Christine M Fisher; Brian D Kavanagh; Elaine T Lam; Sana D Karam
Journal:  Pract Radiat Oncol       Date:  2015-06-30

8.  Elevated DLL4 expression is correlated with VEGF and predicts poor prognosis of nasopharyngeal carcinoma.

Authors:  Jia-Xing Zhang; Man-Bo Cai; Xiao-Pai Wang; Li-Ping Duan; Qiong Shao; Zhu-Ting Tong; Ding-Zhun Liao; Yang-Yang Li; Ma-Yan Huang; Yi-Xin Zeng; Jian-Yong Shao
Journal:  Med Oncol       Date:  2012-12-30       Impact factor: 3.064

Review 9.  Radiation and inflammation.

Authors:  Dörthe Schaue; Ewa D Micewicz; Josephine A Ratikan; Michael W Xie; Genhong Cheng; William H McBride
Journal:  Semin Radiat Oncol       Date:  2015-01       Impact factor: 5.934

Review 10.  Radiobiological basis of SBRT and SRS.

Authors:  Chang W Song; Mi-Sook Kim; L Chinsoo Cho; Kathryn Dusenbery; Paul W Sperduto
Journal:  Int J Clin Oncol       Date:  2014-07-05       Impact factor: 3.402

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.